Altogether, these data indicate that INPP4B has minimal effect on the sensitivity of PIK3CA-mutant ER+ breast cancer cells in monolayer culture to estrogen or PI3Kα-targeted therapies. The gene discussed is INPP4B; the disease is breast cancer.